Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Adverse Outcomes
22%
All-cause Hospitalization
11%
Clinical Course
11%
Clinical High Risk
11%
Clinical Prognosis
11%
Clinically Significant
11%
Comorbidity
11%
Confidence Interval
11%
Congestive Heart Failure
100%
Constitutional Symptoms
11%
Elderly Patients
100%
Elderly People
11%
Follow-up Outcomes
11%
Free Survival
44%
Hazard Ratio
33%
Heart Failure Hospitalization
33%
Increasing Prevalence
11%
Independent Risk Factors
11%
Inflammation
11%
Inflammatory Syndrome
11%
Multivariate Model
11%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
11%
Overall Survival
11%
Pathophysiology
11%
Patient Management
11%
Patients Included
11%
Prognostic Impact
100%
Renal Function
11%
Risk Factors
11%
Risk Factors for Survival
11%
Risk Stratification
11%
Systemic Inflammatory Diseases
100%
INIS
brain
9%
comparative evaluations
9%
diseases
100%
hazards
27%
heart failure
100%
increasing
9%
inflammation
100%
kidneys
9%
management
9%
morbidity
9%
multivariate analysis
9%
organs
9%
patients
100%
peptides
9%
populations
9%
risks
27%
stratification
9%
symptoms
9%
Medicine and Dentistry
Adverse Outcome
22%
Amino Terminal Sequence
11%
Brain Natriuretic Peptide
11%
Comorbidity
11%
Congestive Heart Failure
55%
Constitutional Symptoms
11%
Disease Course
11%
Elderly Patient
100%
Elderly Population
11%
Hazard Ratio
33%
Inflammatory Disorder
100%
Kidney Function
11%
Overall Survival
11%
Pathophysiology
11%
Patient Care
11%
Patient with Congestive Heart Failure
100%
Prevalence
11%
Risk Stratification
11%
Serositis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
22%
Brain Natriuretic Peptide
11%
Comorbidity
11%
Congestive Heart Failure
100%
Disease Course
11%
Inflammation
22%
Inflammatory Disease
100%
Overall Survival
11%
Pathophysiology
11%
Prevalence
11%